Literature DB >> 15346652

Involvement of ceramide in the mechanism of Cr(VI)-induced apoptosis of CHO cells.

Shikibu Muranaka1, Tomoko Kanno, Hirofumi Fujita, Hirotsugu Kobuchi, Jitsuo Akiyama, Tatsuji Yasuda, Kozo Utsumi.   

Abstract

Mitochondria reduce Cr(VI) to Cr(V) with concomitant generation of reactive oxygen species, thereby exhibiting cytotoxic effects leading to apoptosis in various types of cells. To clarify the mechanism by which Cr(VI) induces apoptosis, we examined the effect of Cr(VI) on Chinese hamster ovary (CHO) cells. Cr(VI) increased cellular levels of ceramide by activating acid sphingomyelinase (ASMase) and inhibiting the phosphorylation of pleckstrin homology domain-containing protein kinase B (Akt). Cr(VI) also induced cyclosporin A- and trifluoperazine-sensitive depolarization of mitochondria and activated caspase-3, 8 and 9, thereby causing fragmentation of cellular DNA. The presence of desipramine, an inhibitor of ASMase, and membrane permeable pCPT-cAMP suppressed the Cr(VI)-induced activation of caspases and DNA fragmentation. These results suggested that accumulation of ceramide play an important role in the Cr(VI)-induced apoptosis of CHO cells through activation of mitochondrial membrane permeability transition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15346652     DOI: 10.1080/10715760410001694035

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  2 in total

1.  AKT1 mediates bypass of the G1/S checkpoint after genotoxic stress in normal human cells.

Authors:  Madhu A Lal; Dongsoon Bae; Tura C Camilli; Steven R Patierno; Susan Ceryak
Journal:  Cell Cycle       Date:  2009-05-25       Impact factor: 4.534

2.  Calcium-independent phospholipase A2 (iPLA2 beta)-mediated ceramide generation plays a key role in the cross-talk between the endoplasmic reticulum (ER) and mitochondria during ER stress-induced insulin-secreting cell apoptosis.

Authors:  Xiaoyong Lei; Sheng Zhang; Alan Bohrer; Sasanka Ramanadham
Journal:  J Biol Chem       Date:  2008-10-20       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.